Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2026-03-05 @ 11:54 AM
Study NCT ID:
NCT07010302
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-11
First Post:
2025-05-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
Sponsor:
Organization: